Haemonetics
- Market cap
- 4.63B
- P/E (TTM)i
- 49.14
- P/Bi
- 5.53
- EPSi
- 2.05
- Div yieldi
- 0.00%
- 52W posi
- 86%
Anonymous reader poll. Unscientific, not investment advice.
Haemonetics shares were changing hands at 101.71, down 1.75% on the day. The company carries a market value of roughly 4.63B, the #2165 most valuable US-listed company we track. The trailing P/E of 49.96 is 18% above its five-year average of 42.30. Wall Street's 7-analyst consensus lands on Buy, with a price target averaging 116.67 (+15% from here). Over the past year the stock has ranged from 48.55 to 110.45; it now sits 86% up that band.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 6% of the universe, above its 200-day average.
- Signal has read BUY for 2 months.
- Recent price momentum is +71.2% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 7.5% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 103.52
- Open
- 103.48
- Day range
- 101.32 - 104.02
- Avg price
- 102.22
- Volume
- 625.58K
- Turnover
- 63.94M
- Turnover ratei
- 1.39%
- Volume ratioi
- 1.24
- Amplitudei
- 2.61%
- 52-week rangei
- 48.55 - 110.45
Valuation
- P/Ei
- 49.61
- P/E (TTM)i
- 49.14
- P/Bi
- 5.53
- EPSi
- 2.05
- Book value / shi
- 18.40
- Net profit
- 93.27M
- Net assets
- 837.10M
Share structure
- Market cap
- 4.63B
- Float capi
- 4.57B
- Shares out
- 45.50M
- Float sharesi
- 44.89M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
7.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-7.18M net over the window
Short interest
- Shares short
- 3.42M
- % of floati
- 7.53%
- Days to coveri
- 5.69
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Haemonetics (HAE)?
Haemonetics last traded at 101.71. The quote on this page refreshes every few seconds while US markets are open.
What is Haemonetics's market cap?
About 4.63B.
What is the P/E ratio of Haemonetics?
The trailing twelve-month P/E is 49.14, above its own 5-year average of 42.30 — toward the top of its historical range (73.42% percentile). See the Valuation tab for the full history.
Does Haemonetics pay a dividend?
Haemonetics does not currently pay a regular dividend.
Is Haemonetics a buy according to analysts?
The consensus of 7 analysts is a Buy rating, with an average 12-month price target of 116.67, which implies 14.7% upside from the current price. This is not investment advice.
What is Haemonetics's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Haemonetics a B (Buy). Twelve-month momentum in the top 6% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-08 08:19:22 · For reference only, not investment advice and not tailored to your situation.